What are the new migraine pills prescribed by the NHS?

The NHS is rapidly adopting new CGRP-targeting pills, specifically atogepant and rimegepant, to treat and prevent migraines.

How do the new NHS migraine tablets work?

These tablets work by preventing the release of calcitonin gene-related peptide (CGRP), a protein linked to inflammation in the brain's coverings during migraine attacks.

Are the new migraine tablets more effective than older treatments?

Yes, patient testimonials indicate these tablets are life-changing, offering relief where older treatments like antidepressants and beta-blockers had severe side effects or failed.

Home / Health / Thousands Find Relief with New NHS Migraine Tablets

Thousands Find Relief with New NHS Migraine Tablets

25 Feb

•

Summary

New CGRP-blocking pills rapidly adopted by the NHS.
Migraine sufferers report life-changing positive outcomes.
Tablets offer an easier alternative to injections or infusions.

Thousands Find Relief with New NHS Migraine Tablets

The NHS has seen a rapid take-up of new CGRP-targeting migraine medications, with the regulator heralding them as life-changing for thousands. Atogepant and rimegepant, approved for use in England from 2023 and 2024 respectively, work by preventing the release of calcitonin gene-related peptide (CGRP), a key protein linked to migraine attacks. These are the first CGRP therapies available as easy-to-take tablets, offering a significant improvement over previous infusion or injection methods.

Patient testimonials highlight the profound impact of these pills. One individual, previously suffering a decade of migraines, reported a complete absence of headaches since starting atogepant, stating it has "restored my life." Previously, many relied on older preventive treatments like antidepressants or beta-blockers, which often had severe side effects and were not specifically designed for migraines.